RNA pioneer BioNTech has completed construction of its first proprietary plasmid DNA manufacturing facility in Marburg, ...
Pfizer expects to see a 64% drop in Comirnaty revenues this year, which will hit its 2023 revenue guidance. FY2022 revenues ...
Here at BioPharmaReporter, we put our audience at the heart of what we do. For many years, we have provided our readers with a 360-degree view of the biopharma industry and our editorial standards ...
Biotechnology company, Prothena, has announced positive topline P1 SAD study results for PRX005, an investigational ...
Vector BioMed, a CDMO specializing in the manufacture of lentiviral vectors, launched this week; its first financing round ...
UK based, Aptamer Group, and Hong Kong headquartered, BaseCure Therapeutics, are paring up on the development of ...
US senators, Elizabeth Warren and Peter Welch, are urging Moderna to reconsider the proposed price increases for its COVID-19 ...
Amgen is launching Amjevita, or adalimumab-atto, a biosimilar to AbbVie’s Humira, is now available in the US; it is the first ...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive ...
Phase 3 data for efanesoctocog alfa has been published in the New England Journal of Medicine (NEJM): ahead of a decision on ...
The European Commission (EC) has expanded the marketing authorization for Regeneron and Sanofi’s Dupixent (dupilumab) in the ...
Evotec has entered into a strategic collaboration and licence agreement with Janssen Biotech: with the partnership focusing ...